“Most experimental vaccines tested to date don’t seem to induce strong or protective immune responses,” Crowe said. Even when they work well, he said, they tend to only prevent infection with a single strain and not the many strains of HIV that infect people.In the study, the researchers piggybacked an experimental HIV vaccine onto two types of cold virus — adenovirus serotype 26 and adenovirus serotype 35. These cold viruses are rare, Crowe said, so most humans wouldn’t have developed immunity to them.The researchers then injected 217 healthy people not infected with HIV in Boston and parts of Africa (Kenya, Rwanda and South Africa) with at least one cold virus/HIV vaccine combo or a placebo. Seventy-eight percent of the subjects were black. Seven participants dropped out and didn’t finish follow-up tests.
217!! Wow! Say, could you send the study data? 217 mental assessments? 217 consents?
Ok, you sold me…let’s roll up our sleeves everyone and head out to Disney Land!!